Aralez Pharmaceuticals Announces Certain Organizational Changes in Connection With the Winding Down of its Operations
MISSISSAUGA, ON, Jan. 18, 2019 /CNW/ - Aralez Pharmaceuticals Inc. (the "Company") announced today it has filed a current report on Form 8-K regarding certain organizational changes in connection with the winding down of its operations in connection with its bankruptcy proceedings.
A copy of the current report on Form 8-K filed in connection with such organizational changes with respect to the winding down of the Company's operation is incorporated by reference herein and has been filed on EDGAR at www.sec.gov and on SEDAR at www.sedar.com.
Additional Information
Information about the Company and the court-supervised proceedings are available at a website administered by the Company's claims agent, Primeclerk, at https://cases.primeclerk.com/Aralez. Information is also available at a website maintained by Richter Advisory Group Inc., the Company's court-appointed monitor in Canada, in accordance with the Canadian court proceedings, at http://insolvency.richter.ca/A/Aralez-Pharmaceuticals.
LifeLabs workers from Orillia, Barrie, Collingwood, and Wasaga Beach will rally with community members and allies ahead of their imminent strike deadline. They stand firm in their demands for a fair contract that puts patients and workers before...
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
